Vanda Pharmaceuticals reported $-6967000 in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Agios Pharmaceuticals AGIO:US USD -89109000 6.24M
Akebia Therapeutics AKBA:US USD -38570000 96.43M
Alnylam Pharmaceuticals ALNY:US USD -247440000 65.85M
Arrowhead Research ARWR:US USD -81170000 10.86M
AstraZeneca AZN:LN USD 3.6B 404M
Bluebird Bio BLUE:US USD -85093000 14.32M
Bristol Myers Squibb BMY:US USD 5.32B 456M
Clovis Oncology CLVS:US USD -42347000 15.13M
Eli Lilly And LLY:US USD 2.31B 308.9M
Esperion Therapeutics ESPR:US USD -41518000 10.71M
Halozyme Therapeutics HALO:US USD 112.9M 66.29M
Insmed INSM:US USD -119864000 21.78M
Intercept Pharmaceuticals ICPT:US USD -10064000 808K
Johnson & Johnson JNJ:US USD 7.34B 1.2B
Minerva Neurosciences NERV:US USD -5205000 1.76M
Moderna Inc MRNA:US USD 1.28B 1.24B
Novartis NVS:US USD 4.69B 34M
Pfizer PFE:US USD 10.52B 2.78B
Ptc Therapeutics PTCT:US USD -33710000 29.47M
Sangamo Biosciences SGMO:US USD -51845000 8.99M
Takeda 4502:JP JPY 272.27B 36.53B
Teva Pharmaceutical TEVA:IT USD 1.06B 31M
Ultragenyx Pharmaceutical RARE:US USD -220372000 83.26M
Veracyte VCYT:US USD -3356000 2.42M